14508 Federal Register / Vol. 89, No. 39 / Tuesday, February 27, 2024 / Notices 

1Sections 2604(c)(2), 2612(b)(2), and 2651(c)(2) of 

the PHS Act. 

permissible amounts for administrative 

and CQM costs. However, on the prior 

version of the form, the portion of HIV 

service dollars to be allocated to core 

medical and support services was 

sometimes unclear. The suggested 

change adds a requirement to include 

the proposed percentages of HIV service 

dollars allocated to core medical and 

support services on the form. The table 

on the prior form is expanded to allow 

for the insertion of the proposed 

percentages for core medical and 

support services. Instructions at the top 

of the new form are updated to indicate 

where to insert the proposed 

percentages. Language within the table 

is also updated to increase readability. 

The proposed changes do not modify 

the underlying requirements necessary 

to obtain a waiver: all core medical 

services are available and accessible 

within 30 days in the jurisdiction or 

service area; ensuring that the state 

ADAP has no waiting lists; and that the 

recipient has used a public process to 

determine the need for a waiver. 

Recipients may still need to provide 

supportive evidence to HRSA upon 

request. 

Need and Proposed Use of the 

Information: HRSA uses the 

documentation submitted in core 

medical services waiver requests to 

determine if the RWHAP Parts A, B, and 

C grant applicant or recipient meets the 

statutory requirements for waiver 

eligibility including: (1) no waiting lists 

for ADAP services; and (2) evidence of 

core medical services availability within 

the grant recipient’s jurisdiction, state, 

or service area to all persons with HIV 

identified and eligible under Title XXVI 

of the Public Health Service Act.1

Likely Respondents: HRSA expects 

responses from RWHAP Parts A, B, and 

C grant applicants and recipients. The 

number of grant recipients requesting 

waivers has fluctuated annually and 

ranged up to 23 per year since its 

implementation in fiscal year 2007. In 

light of recent trends, HRSA anticipates 

receiving possibly up to 23 applications 

in a given year. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating, and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

Total Estimated Annualized Burden 

Hours: 

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total 

burden 

hours 

RWHAP ........................................................................................

Core Medical Services Waiver Request Attestation Form .......... 23 1 23 0.49 11.27 

Total ...................................................................................... 23 1 23 0.49 11.27 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2024–03952 Filed 2–26–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

HIV/AIDS Intra- and Inter-personal 

Determinants and Behavioral Interventions 

Study Section. 

Date: March 20–21, 2024. 

Time: 8:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street 

NW, Washington, DC 20036. 

Contact Person: Mark P Rubert, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, 301–806– 

6596, rubertm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Aging and Development, Auditory 

Vision and Low Vision Technologies. 

Date: March 20–21, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Canopy by Hilton, 940 Rose Avenue, 

North Bethesda, MD 20852. 

Contact Person: Barbara Susanne Mallon, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 480–8992, mallonb@

mail.nih.gov. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 39 / Tuesday, February 27, 2024 / Notices 14509 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; P30: Mature 

Synchrotron Resource. 

Date: March 20–21, 2024. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Alexei A Yeliseev, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 443–0552, yeliseeva@

mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Biomedical Data Repositories and 

Knowledgebases. 

Date: March 20, 2024. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Joseph Thomas Peterson, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7814, Bethesda, MD 20892, 301–408– 

9694, petersonjt@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Implementation of Biomedical HIV 

Prevention Options for Women. 

Date: March 20, 2024. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Paul Hewett, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 

Bethesda, MD 20892, (240) 672–8946, 

hewettmarxpn@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Respiratory, 

Cardiac, and Circulatory Sciences Member 

Conflict—Cardiac and Respiratory Sciences. 

Date: March 20, 2024. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Carmen Bertoni, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 805B 

Bethesda, MD 20892, (301) 867–5309, 

bertonic2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Infectious Diseases and 

Immunology B Review Panel. 

Date: March 20–21, 2024. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Diana Maria Ortiz-Garcia, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 594–5614, diana.ortiz-garcia@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Radiation Therapy, Radiation 

Biology and Nanoparticle Based 

Therapeutics. 

Date: March 20–21, 2024. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jennifer Ann Sanders, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 496–3553, jennifer.sanders@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Neuroimmunology, Brain Tumors, 

and Neurological Injuries. 

Date: March 20, 2024. 

Time: 11:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Vilen A Movsesyan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4040M, 

MSC 7806, Bethesda, MD 20892, 301–402– 

7278, movsesyanv@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Motor, Pain, and Chemosensory. 

Date: March 20, 2024. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kirk Thompson, Ph.D, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5184, 

MSC 7844, Bethesda, MD 20892, 301–435– 

1242, kgt@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Topics in Infection and Immunity. 

Date: March 20, 2024. 

Time: 12:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Xinrui Li, Ph.D, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892 (301) 594–2084 

xinrui.li@nih.gov 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Myalgic 

Encephalomyelitis–Chronic Fatigue 

Syndrome. 

Date: March 20, 2024. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Roger Janz, Ph.D, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 402–8515, janzr2@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 21, 2024. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–03916 Filed 2–26–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: The Cancer Drug Development and 

Therapeutics (CDDT). 

Date: March 21–22, 2024. 

Time: 8:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW, 

Washington, DC 20015. 

Contact Person: Lilia Topol, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6192, 

MSC 7804, Bethesda, MD 20892, 301–451– 

0131, ltopol@mail.nih.gov. 


lotter on DSK11XQN23PROD with NOTICES1